Table 3.

MiR-212-3p is an prognostic biomarker for patients with HGSOC

	Univariate		Multivariate
	HR (95% CI)	P	HR (95% CI)	P
miR-212-3p (low vs overexpression)	0.206 (0.070-0.611)	0.004*	0.151 (0.019-1.214)	0.075
Age (< 53 vs ≥ 53)	1.952 (0.931-4.090)	0.076
FIGO stage (I-II vs III-IV)	7.393 (2.136-25.584)	0.002**	5.612 (1.133-27.797)	0.035*
Chemotherapy response (sensitive vs partial)	1.393 (0.373-4.976)	0.64
Ascites (no vs yes)	1.567 (0.713-3.443)	0.264

^*p < 0.05;

^**p < 0.01.